\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgical\\ resection\ \(126\)\
\-\ the\\ immunostain\\ results\\ \\(positive\\ r132h\\ idh1\\ staining\\,\\ clonal\\ p53\\ positivity\\,\\ and\\ negative\\ egfr\\ expression\\)\\ are\\ consistent\\ with\\ the\\ diagnosis\\ of\\ a\\ diffuse\\ fibrillary\\ astrocytoma\\.\\ \\ \ \(0\)\
\-\ the\\ following\\ immunostain\\ results\\ were\\ obtained\\ on\\ b14\\:\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\-\\ p53\\:\\ strong\\ clonal\\ staining\\ in\\ tumor\\ cells\\.\ \(1\)\
\-\ \\ \\ \\ \\ \\ \\ \\-\\ idh1\\ \\(r132h\\)\\:\\ strongly\\ positive\\ in\\ tumor\\ cells\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\-\\ egfr\\:\\ negative\\ in\\ tumor\\ cells\\.\ \(0\)\
\-\ on\\ the\\ basis\\ of\\ focal\\ increased\\ cellularity\\ and\\ atypia\\,\\ increased\\ mitotic\\ activity\\ \\(at\\ least\\ three\\ high\\-power\\-fields\\ containing\\ two\\ mitoses\\ each\\ are\\ noted\\)\\,\\ focal\\ perivascular\\ macrophages\\,\\ and\\ focal\\ minor\\/rudimentary\\ microvascular\\ proliferation\\,\\ it\\ is\\ felt\\ that\\ the\\ tumor\\ may\\ be\\ more\\ aggressive\ \(0\)\
\-\ than\\ is\\ usual\\ for\\ grade\\ 2\\ astrocytomas\\.\ \(1\)\
\-\ minimally\\ enhancing\\ mass\\ left\\ temporal\\ lobe\\.\ \(0\)\
\-\ moderate\\ amount\\ of\\ edema\\.\\ \\ no\\ hemorrhage\\.\ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ who\\ 2\\-3\\,\\ temporal\\ lobe\ \(0\)\
\-\ \\â\\€\\¢\\ herpes\\ encephalitis\ \(0\)\
\-\ \\â\\€\\¢\\ resolving\\ hematoma\ \(0\)\
\-\ \\â\\€\\¢\\ dnet\ \(0\)\
\-\ \\â\\€\\¢\\ infiltrating\\ glial\\ neoplasm\\ \\-\\ astrocytoma\\ vs\\.\\ oligodendrglioma\ \(0\)\
\-\ 23\\ year\\ old\\ man\\ presents\\ with\\ a\\ first\\ time\\ seizure\\.\\ no\\ fever\\.\ \(0\)\
\-\ 1st\\ mri\\ head\\:\\ \\"\\.\\.\\.\\.masslike\\ expansion\\ of\\ the\\ left\\ temporal\\ lobe\\ involving\\ primarily\\ the\\ medial\\ aspect\\ with\\ cortical\\ thickening\\ of\\ the\\ mesial\\ temporal\\ lobe\\ and\\ hippocampus\\ \\.\\ there\\ is\\ elevated\\ t2\\ hyperintense\\ signal\ \(0\)\
\-\ involving\\ the\\ temporal\\ lobe\\ extending\\ through\\ the\\ white\\ matter\\ tracts\\ cephalad\\ to\\ the\\ left\\ basal\\ ganglia\\ and\\ above\\ the\\ left\\ occipital\\ trigone\\ and\\ medial\\ aspect\\ of\\ the\\ left\\ occipital\\ lobe\\.\\ the\\ inferomedial\\ left\\ frontal\\ lobe\\ and\\ anterior\\ commissure\\ also\\ shows\\ t2\\ hyperintense\\ signal\\ and\\ there\\ is\ \(0\)\
\-\ cortical\\ thickening\\ of\\ the\\ left\\ frontal\\ lobe\\.\\ there\\ is\\ no\\ evidence\\ for\\ enhancement\\ within\\ this\\ region\\ although\\ a\\ number\\ of\\ enhancing\\ prominent\\ medullary\\ vessels\\ course\\ through\\ the\\ above\\ area\\.\\ \\.\\.\\.\\ findings\\ are\\ concerning\ \(0\)\
\-\ for\\ encephalitis\\ or\\ infiltrating\\ glioma\\.\\.\\.\\"\ \(1\)\
\-\ 2nd\\ mri\\ head\\ three\\ week\\ later\\:\\ \\"\\.\\.\\.impression\\:\\ 1\\.\\ study\\ obtained\\ for\\ stereotactic\\ localization\\ of\\ lesion\\ centered\\ within\\ the\\ left\\ temporal\\ lobe\\.\\ this\\ lesion\\ has\\ not\\ significantly\\ changed\\ since\\ the\\ prior\\ studies\\.\\ this\\ is\\ likely\\ a\\ glioma\\.\\"\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lobe\\:\\ 0\\.29473732545005027\ \(0\)\
\-\ temporal\\:\\ 0\\.26118914862144577\ \(0\)\
\-\ the\\:\\ 0\\.20353470488421127\ \(0\)\
\-\ immunostain\\:\\ 0\\.1731955517180564\ \(0\)\
\-\ r132h\\:\\ 0\\.1731955517180564\ \(0\)\
\-\ clonal\\:\\ 0\\.1731955517180564\ \(0\)\
\-\ idh1\\:\\ 0\\.16747971558896937\ \(0\)\
\-\ egfr\\:\\ 0\\.16747971558896937\ \(0\)\
\-\ p53\\:\\ 0\\.16304616864701207\ \(0\)\
\-\ left\\:\\ 0\\.15464777232906515\ \(0\)\
\-\ staining\\:\\ 0\\.1318799876616616\ \(0\)\
\-\ cells\\:\\ 0\\.13098758501278104\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.12833949968970584\ \(0\)\
\-\ tumor\\:\\ 0\\.11856432972312317\ \(0\)\
\-\ encephalitis\\:\\ 0\\.11270519443911146\ \(0\)\
\-\ infiltrating\\:\\ 0\\.11118777130703211\ \(0\)\
\-\ focal\\:\\ 0\\.10169018604660562\ \(0\)\
\-\ of\\:\\ 0\\.09980854085067663\ \(0\)\
\-\ occipital\\:\\ 0\\.09698240299196327\ \(0\)\
\-\ glioma\\:\\ 0\\.0962802597343538\ \(0\)\
\-\ and\\:\\ 0\\.09367934816511307\ \(0\)\
\-\ is\\:\\ 0\\.09311485345196485\ \(0\)\
\-\ b14\\:\\ 0\\.09062578513721715\ \(0\)\
\-\ oligodendrglioma\\:\\ 0\\.09062578513721715\ \(0\)\
\-\ hyperintense\\:\\ 0\\.0901547475147653\ \(0\)\
\-\ results\\:\\ 0\\.08831643896039477\ \(0\)\
\-\ masslike\\:\\ 0\\.0865977758590282\ \(0\)\
\-\ positivity\\:\\ 0\\.08373985779448469\ \(0\)\
\-\ commissure\\:\\ 0\\.08373985779448469\ \(0\)\
\-\ above\\:\\ 0\\.08176366896982265\ \(0\)\
\-\ hippocampus\\:\\ 0\\.08152308432350604\ \(0\)\
\-\ cortical\\:\\ 0\\.08136891585643484\ \(0\)\
\-\ obtained\\:\\ 0\\.08016822262159792\ \(0\)\
\-\ fibrillary\\:\\ 0\\.07971184851629573\ \(0\)\
\-\ involving\\:\\ 0\\.07938660406218265\ \(0\)\
\-\ thickening\\:\\ 0\\.07710546651180367\ \(0\)\
\-\ mitoses\\:\\ 0\\.07685393045175223\ \(0\)\
\-\ three\\:\\ 0\\.07608108571286343\ \(0\)\
\-\ atypia\\:\\ 0\\.07568383923810676\ \(0\)\
\-\ mitotic\\:\\ 0\\.07568383923810676\ \(0\)\
\-\ inferomedial\\:\\ 0\\.07568383923810676\ \(0\)\
\-\ positive\\:\\ 0\\.07468368813221997\ \(0\)\
\-\ microvascular\\:\\ 0\\.07463715698077357\ \(0\)\
\-\ mesial\\:\\ 0\\.07463715698077357\ \(0\)\
\-\ medial\\:\\ 0\\.07377421190436864\ \(0\)\
\-\ expression\\:\\ 0\\.07369031770686184\ \(0\)\
\-\ cellularity\\:\\ 0\\.07369031770686184\ \(0\)\
\-\ glial\\:\\ 0\\.07369031770686184\ \(0\)\
\-\ aspect\\:\\ 0\\.07311842344931382\ \(0\)\
\-\ frontal\\:\\ 0\\.07294714147080888\ \(0\)\
\-\ trigone\\:\\ 0\\.07203075344466867\ \(0\)\
\-\ diffuse\\:\\ 0\\.07107673279071489\ \(0\)\
\-\ enhancing\\:\\ 0\\.07099927231654554\ \(0\)\
\-\ macrophages\\:\\ 0\\.0706091477025846\ \(0\)\
\-\ negative\\:\\ 0\\.07016656206345043\ \(0\)\
\-\ for\\:\\ 0\\.06870354158864951\ \(0\)\
\-\ cephalad\\:\\ 0\\.0682607922651829\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.0677512296380411\ \(0\)\
\-\ there\\:\\ 0\\.06764504664502763\ \(0\)\
\-\ head\\:\\ 0\\.0675970611709699\ \(0\)\
\-\ through\\:\\ 0\\.06746720066646737\ \(0\)\
\-\ perivascular\\:\\ 0\\.06726653384047716\ \(0\)\
\-\ stereotactic\\:\\ 0\\.06726653384047716\ \(0\)\
\-\ tracts\\:\\ 0\\.0663627935201923\ \(0\)\
\-\ t2\\:\\ 0\\.06520627653142223\ \(0\)\
\-\ localization\\:\\ 0\\.06476990261718532\ \(0\)\
\-\ are\\:\\ 0\\.06450972336613373\ \(0\)\
\-\ signal\\:\\ 0\\.06424788941536747\ \(0\)\
\-\ herpes\\:\\ 0\\.06339747664499235\ \(0\)\
\-\ changed\\:\\ 0\\.06339747664499235\ \(0\)\
\-\ dnet\\:\\ 0\\.0627763810859404\ \(0\)\
\-\ resolving\\:\\ 0\\.062479812996248524\ \(0\)\
\-\ increased\\:\\ 0\\.06128760987631385\ \(0\)\
\-\ proliferation\\:\\ 0\\.06086530229530864\ \(0\)\
\-\ basis\\:\\ 0\\.060619998641238834\ \(0\)\
\-\ strong\\:\\ 0\\.05905406648809833\ \(0\)\
\-\ 1st\\:\\ 0\\.05905406648809833\ \(0\)\
\-\ centered\\:\\ 0\\.05905406648809833\ \(0\)\
\-\ usual\\:\\ 0\\.058849228442847575\ \(0\)\
\-\ this\\:\\ 0\\.05841728452143307\ \(0\)\
\-\ mri\\:\\ 0\\.05817749120187811\ \(0\)\
\-\ strongly\\:\\ 0\\.057004259858813834\ \(0\)\
\-\ no\\:\\ 0\\.055284169457730334\ \(0\)\
\-\ impression\\:\\ 0\\.05516500063886212\ \(0\)\
\-\ primarily\\:\\ 0\\.054359075688310804\ \(0\)\
\-\ concerning\\:\\ 0\\.054359075688310804\ \(0\)\
\-\ lesion\\:\\ 0\\.05433658895283043\ \(0\)\
\-\ each\\:\\ 0\\.05373407129850637\ \(0\)\
\-\ minimally\\:\\ 0\\.05373407129850637\ \(0\)\
\-\ ganglia\\:\\ 0\\.05326092029390851\ \(0\)\
\-\ significantly\\:\\ 0\\.05326092029390851\ \(0\)\
\-\ least\\:\\ 0\\.05237728988581319\ \(0\)\
\-\ within\\:\\ 0\\.05219982500496913\ \(0\)\
\-\ number\\:\\ 0\\.052168139145365874\ \(0\)\
\-\ 2nd\\:\\ 0\\.05186244446501896\ \(0\)\
\-\ expansion\\:\\ 0\\.05166375197717377\ \(0\)\
\-\ containing\\:\\ 0\\.05090648697731492\ \(0\)\
\-\ medullary\\:\\ 0\\.050118332516081374\ \(0\)\
\-\ felt\\:\\ 0\\.049787158741928544\ \(0\)\
\-\ aggressive\\:\\ 0\\.049004526400475465\ \(0\)\
\-\ basal\\:\\ 0\\.048491201495981635\ \(0\)\
\-\ seizure\\:\\ 0\\.04715573178395488\ \(0\)\
\-\ 23\\:\\ 0\\.04672772680590775\ \(0\)\
\-\ amount\\:\\ 0\\.04533408812536904\ \(0\)\
\-\ prominent\\:\\ 0\\.04463137048479524\ \(0\)\
\-\ vessels\\:\\ 0\\.04397509368231937\ \(0\)\
\-\ vs\\:\\ 0\\.043232405173348906\ \(0\)\
\-\ matter\\:\\ 0\\.0431485709776975\ \(0\)\
\-\ moderate\\:\\ 0\\.0425413987471045\ \(0\)\
\-\ in\\:\\ 0\\.04229209222782097\ \(0\)\
\-\ course\\:\\ 0\\.041858621408052014\ \(0\)\
\-\ activity\\:\\ 0\\.04160527415324917\ \(0\)\
\-\ studies\\:\\ 0\\.041569603403149476\ \(0\)\
\-\ since\\:\\ 0\\.041049364479193676\ \(0\)\
\-\ grade\\:\\ 0\\.040749815356252335\ \(0\)\
\-\ later\\:\\ 0\\.040555019051702224\ \(0\)\
\-\ hematoma\\:\\ 0\\.039663867066655235\ \(0\)\
\-\ neoplasm\\:\\ 0\\.038685016079020584\ \(0\)\
\-\ elevated\\:\\ 0\\.03863189138969742\ \(0\)\
\-\ although\\:\\ 0\\.03857904927984505\ \(0\)\
\-\ fever\\:\\ 0\\.03842218875940082\ \(0\)\
\-\ extending\\:\\ 0\\.03842218875940082\ \(0\)\
\-\ first\\:\\ 0\\.038242261324571175\ \(0\)\
\-\ week\\:\\ 0\\.03811570810704281\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.03794119909626871\ \(0\)\
\-\ study\\:\\ 0\\.03779402168986216\ \(0\)\
\-\ white\\:\\ 0\\.03738848402609381\ \(0\)\
\-\ area\\:\\ 0\\.03671088326967405\ \(0\)\
\-\ resection\\:\\ 0\\.03632545286355318\ \(0\)\
\-\ on\\:\\ 0\\.03422991462297688\ \(0\)\
\-\ following\\:\\ 0\\.033995907142178865\ \(0\)\
\-\ region\\:\\ 0\\.03389672868220187\ \(0\)\
\-\ likely\\:\\ 0\\.033863888013519874\ \(0\)\
\-\ edema\\:\\ 0\\.03379853058548495\ \(0\)\
\-\ two\\:\\ 0\\.03365302979240811\ \(0\)\
\-\ time\\:\\ 0\\.03358904056486037\ \(0\)\
\-\ with\\:\\ 0\\.03328939214335062\ \(0\)\
\-\ shows\\:\\ 0\\.03325969681617633\ \(0\)\
\-\ enhancement\\:\\ 0\\.03261758814931953\ \(0\)\
\-\ evidence\\:\\ 0\\.03216530893078675\ \(0\)\
\-\ than\\:\\ 0\\.03212394470768373\ \(0\)\
\-\ who\\:\\ 0\\.03205538478595251\ \(0\)\
\-\ prior\\:\\ 0\\.031706306137095845\ \(0\)\
\-\ anterior\\:\\ 0\\.03164055941645099\ \(0\)\
\-\ more\\:\\ 0\\.031117245087577017\ \(0\)\
\-\ consistent\\:\\ 0\\.03072713682594875\ \(0\)\
\-\ noted\\:\\ 0\\.030045727084235332\ \(0\)\
\-\ man\\:\\ 0\\.030001178609451853\ \(0\)\
\-\ diagnosis\\:\\ 0\\.029376716292232565\ \(0\)\
\-\ were\\:\\ 0\\.029211140905576638\ \(0\)\
\-\ it\\:\\ 0\\.029007978544437017\ \(0\)\
\-\ may\\:\\ 0\\.0285175387205614\ \(0\)\
\-\ findings\\:\\ 0\\.02796833724852903\ \(0\)\
\-\ surgical\\:\\ 0\\.02754289661379737\ \(0\)\
\-\ presents\\:\\ 0\\.027260629087493167\ \(0\)\
\-\ also\\:\\ 0\\.026655390344623917\ \(0\)\
\-\ has\\:\\ 0\\.0258846672472296\ \(0\)\
\-\ that\\:\\ 0\\.024592144100165268\ \(0\)\
\-\ be\\:\\ 0\\.02298827607645105\ \(0\)\
\-\ not\\:\\ 0\\.02237150338983487\ \(0\)\
\-\ mass\\:\\ 0\\.021645977675675034\ \(0\)\
\-\ at\\:\\ 0\\.02140453193150604\ \(0\)\
\-\ or\\:\\ 0\\.019714074524991087\ \(0\)\
\-\ year\\:\\ 0\\.01746421559676951\ \(0\)\
\-\ old\\:\\ 0\\.016771692361153383\ \(0\)\
\-\ to\\:\\ 0\\.01416709448565767\ \(0\)\
